Nivaquin-P syrup 50 mg/5 mL 60 mL

 33.71

Manufactured by:
Active Pharmaceutical Ingredient:
Drug Strength: 50 mg/5 mL
Drug Form : Syrup
Pack Size : 60 ml

Nivaquin-P syrup contains Chloroquine Phosphate | belongs to 4-Aminoquinoline

SKU: pg_16200_22473 Category:

Alternate brands of Nivaquin-P syrup 50 mg/5 mL 60 mL

Brand Name Price Savings
Zoloquine syrup 50 mg/5 mL 450 mL  35.00 You will pay -1.29 more
Zoloquine syrup 50 mg/5 mL 60 mL  12.00 You can save 21.71
Wilquine tablet 250 mg 20×10’s  121.02 You will pay -87.31 more
Wilquine tablet 250 mg 30×10’s  181.54 You will pay -147.83 more
Wilquine tablet 250 mg 1000’s  605.15 You will pay -571.44 more
List of alternate brands

Reviews

There are no reviews yet.

Be the first to review “Nivaquin-P syrup 50 mg/5 mL 60 mL”

How it works

It works by increasing the concentration of a toxic molecule in the parasite thus inhibits the growth of the parasite.

Side effects

Major & minor side effects for Nivaquin-P syrup 50 mg/5 mL 60 mL

  • Blurred vision severe
  • Confusion severe
  • Diarrhea severe
  • Dizziness severe
  • Skin rash severe
  • Hair loss
  • Increased sensitivity of the skin to sunlight

Uses of Nivaquin-P syrup 50 mg/5 mL 60 mL

What is it prescribed for?

  • Malaria prophylaxis

    Nivaquin-P syrup 50 mg/5 mL 60 mL is used as prophylaxis for malaria.

  • Malaria

    Nivaquin-P syrup 50 mg/5 mL 60 mL is used in the treatment of malaria characterized by muscle pain, fever with chills and fatigue.

  • Amebiasis

    Nivaquin-P syrup 50 mg/5 mL 60 mL is used in the amebiasis which is a parasitic infection that affects the intestine and amebic liver abscess caused by Entamoeba histolytica.

Concerns

Frequently asked questions

  • Onset of action

    The effect of this medicine can be observed in 1 to 2 hours.

  • Duration of Effect

    The effect of this medicine lasts for an average duration of 9 to 15 days.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended in pregnant women unless absolutely necessary.

  • Usage while breast-feeding?

    This medicine is known to excreted through breast milk. It is not recommended in for breastfeeding women.

When not to use?

  • Allergy

    Not recommended in patients with known allergy to 4-aminoquinoline compounds.

  • Retinal or visual field changes

    Not recommended in patients with any vision impairment

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended in pregnant women unless absolutely necessary.

  • Breast-feeding

    This medicine is known to excreted through breast milk. It is not recommended in for breastfeeding women.

General Warnings
  • Prolongation of QT interval

    This medicine may increase the risk of irregular heart rhythms. Therefore should be used with caution in patients with arrhythmias or any other heart diseases. Any symptoms of palpitations, difficulty in breathing should be reported to the doctor.

  • Eye disorder

    This medicine may increase the risk of vision problem. This effect depends on the dose and duration of the treatment. Close monitoring of eye function is necessary. Any symptoms of vision problem should be reported to the doctor.

  • Blood cell count

    This medicine may lower the blood cell count if taken for a longer time. Close monitoring of complete blood cell count is necessary. Discontinue the treatment if any signs of low blood cell count appear. It should be used with caution in patients with glucose-6 phosphate dehydrogenase deficiency.

  • Hearing problem

    This medicine may increase the risk of the hearing problem. This medicine should be used with caution in patients with existing hearing problem. Discontinue the treatment if any symptoms are identified.

  • Impaired liver function

    This medicine should be used with caution in liver injury patients. Details of other medications that can affect the liver should be informed to the doctor. Discontinue the treatment if any elevation in the liver enzymes is identified.

  • Psoriasis

    This medicine is not recommended in patients with psoriasis as it may exacerbate the condition. Inform the doctor if you have any skin diseases before initiation of the treatment. It is used only if benefits overweigh risks.

  • Porphyria

    This medicine is not recommended in patients with porphyria as it may exacerbate the condition. Inform the doctor if you have this condition before initiation of the treatment. It is used only if benefits overweigh risks.

Dosage

  • Missed Dose

    If you miss a dose of Nivaquin-P syrup 50 mg/5 mL 60 mL take the missed dose as soon as you remember. If it’s almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Ethambutol moderate
  • Fluconazole moderate
  • Tramadol severe
  • Quinidine severe
Disease interactions
  • severe

    This medicine is not recommended in patients with the eye disorder. Close monitoring of eye function is necessary. The treatment should be discontinued if any symptoms of blurred vision, difficulty in reading appear.

Lab interactions

General Instructions

Take Nivaquin-P syrup 50 mg/5 mL 60 mL as advised by your doctor. Do not take in larger amounts than advised. It is advised to take this medicine at the same time every day. Do not stop taking the medicine without consulting your doctor. Ensure that the course of treatment is completed to prevent the spread of infection. Consult the doctor if you experience any undesirable effects

Other details

  • To be taken with food
  • To be taken as instructed by doctor
  • May cause sleepiness

References

Additional Information>

How to use Nivaquin-P syrup 50 mg/5 mL 60 mL

Administered by IV or IM injection.
Compatibility: Stable in NS.
Stability: Store at 25°C (77°F). Excursions permitted to 15°C-30°C (59°F-86°F).

what are the adverse effects of Nivaquin-P syrup 50 mg/5 mL 60 mL?

Headache, Gl distress. Skin eruptions, depigmentation, hair loss, blurred vision, corneal opacities, retinal damage, blood disorders.

What happens if I miss a dose of Nivaquin-P syrup 50 mg/5 mL 60 mL?

ORAL: Malaria suppressive: Adults: 500 mg weekly. Children: 5 mg/kg (as chloroquine base) at weekly intervals.
Malaria therapeutic: Adults: 1000 mg initially then 500 mg daily.
Hepatic amoebiasis: Adults: 500-1000 mg daily.
INJECTION: Cerebral malaria: Adults: 200-300 mg (chloroquine base) by IV or IM inj.

One of the following licensed pharmacy from the nearest location will deliver Nivaquin-P syrup 50 mg/5 mL 60 mL. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Shopping Cart

Medicalstore.com.pk © All rights reserved

Made with ❤ by Dairah